ctrl K

AI Score

Unlock

Gain Therapeutics Inc. (GANX)

AI Score

Unlock

2.01

-0.12 (-5.63%)

At close: Mar 03, 2025, 12:12 PM

Gain Therapeutics Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	55.18K	140.11K	164.99K	28.88K	41.3K	20.61K
Cost of Revenue	80.38K	64.17K	7.16M	2.26M	n/a	n/a
Gross Profit	-25.2K	75.94K	-7M	-2.23M	41.3K	20.61K
Operating Income	-22.25M	-17.78M	-13.83M	-3.48M	-2.1M	-1.03M
Interest Income	494.23K	375.36K	12.49K	3.64K	20.54K	n/a
Pretax Income	-22.19M	-17.5M	-13.89M	-3.57M	-2.19M	-1.1M
Net Income	-22.27M	-17.59M	-13.89M	-3.58M	-2.19M	-1.11M
Selling & General & Admin	10.79M	9.54M	6.83M	1.25M	555.16K	222.05K
Research & Development	11.52M	8.38M	7.16M	2.26M	1.59M	826.88K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	22.31M	17.92M	13.99M	3.51M	2.14M	1.05M
Interest Expense	n/a	n/a	n/a	n/a	20.54K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	22.31M	17.92M	13.99M	3.51M	2.14M	1.05M
Income Tax	79.28K	92.98K	4.01K	5.39K	7.11K	9.78K
Shares Outstanding (Basic)	13.01M	11.88M	10.17M	11.88M	11.88M	5.86M
Shares Outstanding (Diluted)	13.01M	11.88M	10.17M	11.88M	11.88M	5.86M
EPS (Basic)	-1.71	-1.48	-1.37	-0.3	-0.18	-0.19
EPS (Diluted)	-1.71	-1.48	-1.37	-0.3	-0.18	-0.19
EBITDA	-22.17M	-17.78M	-13.82M	-3.47M	-2.1M	-1.03M
Depreciation & Amortization	83.58K	64.17K	15.48K	9.59K	2.57K	741.00